Kidney News and Research

RSS

As record heat sweeps the us, some people must choose between food and energy bills

During the heat dome that blanketed much of the Southeast in June, Stacey Freeman used window units to cool her poorly insulated mobile home in Fayetteville, North Carolina. Over the winter, the 44-year-old mom relied on space heaters.

6 Sep 2024

Mediterranean diet vs. Ultra-processed foods: Impact on frailty in older adults

Researchers evaluate whether ultra-processed food and Mediterranean diet scores were associated with frailty and cardiometabolic disease in older adults.

6 Sep 2024

Study finds correlation between light pollution and Alzheimer's Disease

In some places around the globe, the lights never go off. Streetlights, roadway lighting, and illuminated signs can deter crime, make roads safer, and enhance landscaping. Undisrupted light, however, comes with ecological, behavioral, and health consequences.

6 Sep 2024

The impact of microgravity on cancer development and treatment

The Wake Forest Institute for Regenerative Medicine (WFIRM) is honored to announce its selection for a pioneering cancer research project that will take place aboard the International Space Station (ISS). The project, one of only five chosen through a competitive solicitation by the ISS National Lab in partnership with NASA, aims to explore the effects of microgravity on cancer development and treatment.

6 Sep 2024

Cancer drug offers life-changing results for severe lupus patient

The team at Charité – Universitätsmedizin Berlin is astounded by the huge improvement seen in a female patient with severe systemic lupus erythematosus (SLE) after being treated with the cancer medication teclistamab. Not long ago, the 23-year-old was wheelchair-bound due to the autoimmune disease.

6 Sep 2024

Weight-loss surgery offers better control of high blood pressure compared to medications

People with obesity who underwent weight-loss surgery were more likely to control their high blood pressure over a 1-to-5 year follow-period compared to those who managed their high blood pressure with medications and lifestyle management, according to preliminary research to be presented at the American Heart Association's Hypertension Scientific Sessions 2024.

5 Sep 2024

Many at-home blood pressure monitors may not fit most U.S. adults

At-home blood-pressure monitor cuffs may improperly fit many adults in the U.S., according to preliminary research presented at the American Heart Association's Hypertension Scientific Sessions 2024 and simultaneously published today in the journal Hypertension.

5 Sep 2024

Breakthrough research identifies key microenvironments linked to kidney injury and disease

A study published in Nature Communications provides new insight into how damaged cells interact within disease-promoting microenvironments following acute kidney injury, or AKI.

5 Sep 2024

New studies highlight elevated blood pressure and unmet social needs in young adults, children

Two separate studies show that elevated blood pressure and unmet social needs are a concern for young adults and children in the U.S. Both studies are preliminary research abstracts presented at the American Heart Association's Hypertension Scientific Sessions 2024.

5 Sep 2024

New program helps 74% of patients achieve blood pressure control

Up to 74% of adults with treatment-resistant high blood pressure were able to get their blood pressure below 140/90 mm HG within one year through a program combining remote blood pressure monitoring with pharmacist interactions, according to preliminary research presented at the American Heart Association's Hypertension Scientific Sessions 2024.

5 Sep 2024

Akebia Therapeutics to present at upcoming investor conferences

Akebia Therapeutics®, Inc., a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that its executives will participate in two investor conferences in September: Wells Fargo Healthcare Conference on September 4-6, 2024 in Boston and H.C. Wainwright 26th Annual Global Investment Conference on September 9-11, 2024 in New York.

From Akebia Therapeutics 4 Sep 2024

Combined use of insulin and metformin enhances diabetic foot ulcer healing, research shows

People with chronic diabetic foot ulcers could soon have a new way to treat their wounds for faster healing and fewer hospital stays.

4 Sep 2024

Mineralocorticoid receptor antagonists reduce risk of cardiovascular events in patients with heart failure

MRAs significantly lower the risk of cardiovascular death and HF hospitalization in heart failure patients.

3 Sep 2024

$FINEARTS-HF trial shows finerenone benefits for heart failure with preserved ejection fraction$

FINEARTS-HF trial shows finerenone benefits for heart failure with preserved ejection fraction

Finerenone reduced heart failure (HF) events and cardiovascular death in patients with HF and mildly reduced (HFmrEF) or preserved ejection fraction (HFpEF), according to late-breaking research presented in a Hot Line session today at ESC Congress 2024.

2 Sep 2024

Complete revascularization proves effective for older STEMI patients in first 4 years

The benefits of complete revascularization over culprit-only coronary artery revascularisation were confirmed in older patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease over the first 4 years, according to late-breaking research presented in a Hot Line session today at ESC Congress 2024.

2 Sep 2024

Pooled analysis shows finerenone reduces all-cause mortality but not cardiovascular death

A pooled analysis of three large trials failed to demonstrate significant reductions in cardiovascular death with finerenone, but significantly lower all-cause mortality, cardiovascular events and kidney outcomes were observed, according to late-breaking research presented in a Hot Line session today at ESC Congress 2024.

2 Sep 2024

Research finds particulate pollution during pregnancy may impact newborn kidney function

Research reveals that gestational exposure to air pollution increases cord blood cystatin C levels, indicating potential kidney function issues in newborns.

2 Sep 2024

New study confirms safety of SGLT2 inhibitors after acute myocardial infarction

The SGLT2 inhibitor empagliflozin confers kidney-protective benefits and can therefore be given safely and effectively to patients when they are hospitalized for acute myocardial infarction (MI), a Mount Sinai-led global team of researchers has shown.

1 Sep 2024

American football head impacts tied to increased brain damage and cognitive decline

Repetitive head impacts in former American football players are linked to increased perivascular space volume, which correlates with cognitive decline and neurodegeneration. The study suggests that the force of head impacts may be more critical than frequency, with potential protective effects from β-blocker use.

1 Sep 2024

Semaglutide's impact on cardiovascular health expands beyond weight loss

Semaglutide, the popular anti-obesity medication originally developed to treat diabetes, continues to show cardiovascular benefits beyond weight loss, including reducing risk of death, reducing serious COVID-19 related events and improving heart failure (HF) symptoms, according to six new substudies published in JACC, the flagship journal of the American College of Cardiology.

30 Aug 2024

Kidney News and Research

As record heat sweeps the us, some people must choose between food and energy bills

Mediterranean diet vs. Ultra-processed foods: Impact on frailty in older adults

Study finds correlation between light pollution and Alzheimer's Disease

The impact of microgravity on cancer development and treatment

Cancer drug offers life-changing results for severe lupus patient

Weight-loss surgery offers better control of high blood pressure compared to medications

Many at-home blood pressure monitors may not fit most U.S. adults

Breakthrough research identifies key microenvironments linked to kidney injury and disease

New studies highlight elevated blood pressure and unmet social needs in young adults, children

New program helps 74% of patients achieve blood pressure control

Akebia Therapeutics to present at upcoming investor conferences

Combined use of insulin and metformin enhances diabetic foot ulcer healing, research shows

Mineralocorticoid receptor antagonists reduce risk of cardiovascular events in patients with heart failure

FINEARTS-HF trial shows finerenone benefits for heart failure with preserved ejection fraction

Complete revascularization proves effective for older STEMI patients in first 4 years

Pooled analysis shows finerenone reduces all-cause mortality but not cardiovascular death

Research finds particulate pollution during pregnancy may impact newborn kidney function

New study confirms safety of SGLT2 inhibitors after acute myocardial infarction

American football head impacts tied to increased brain damage and cognitive decline

Semaglutide's impact on cardiovascular health expands beyond weight loss

Event guide: 8th CKD Summit 2026 eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News